Just wanted to see what other places are doing regarding NMB in pyxis anesthesia stations, or similar. Currently ours are stored in the matrix drawers, so not "lidded". We have issues with having adequate space in the mini drawers to place these as well due to the controlled substances. Are you all labeling pockets within the matrix, securing in mini drawers, or something else entirely?

For those of you that wear compliance hats as well: has anyone been able to implement the new mifepristone REMS that enables community pharmacies to dispense mifepristone?

I know this comes up routinely.... Does anyone have a nurse dual sign requirement for thrombolytics? We had a Stroke Certification survey last fall and TJC was pretty insistent that this be a mandatory requirement. Our process has been to evaluate medications based on ISMP guidance so have not had these meds as a requirement. We have alteplase and tenecteplase on our formulary so both would be required. Interested if others have had this 'recommendation' from TJC and added these to their list or just have them on the list. Thank you.

Wondering if anyone in this group can answer how their team handles a compounding suite shutdown. For example, the suite is shut down for some air handler and room repairs, sometimes for a few hours but up to a couple of days depending on what is being done. Room is terminally cleaned with a sporicidal cleaner and then re-certified by your vendor. Do you typically wait for all the air/surface environmental testing to come back before resuming compounding or do you use the room while awaiting the microbiology results? Thanks!

My organization transitioned to use of ENFit syringes from NeoMed/Avanos in November '22. Since that time we have had an ongoing issue where significant air bubbles form in the morphine oral solution that we package into syringes for our neonate population.

Good Afternoon,

Greetings,

Our organization is reviewing our ADC override policy and procedures and would like to benchmark what other organizations are doing. I created this quick 3-5 minute survey to get some insight of the practice in other organizations. I can also share this to anyone that is interested in the data.

https://childrens.surveymonkey.com/r/ADCoverrides

Thank you in advance,

Jay

Hi Everyone,

It's that time again!

Hi All,

Looking to connect with an organization that has implemented the ISMP best practice around requiring 5 Letters/Characters during ADC drug searches via override. In reading past MSOS threads, most were still in the planning phase or stepped back from 5 characters to 4.

Please share in this thread any learnings or feel free to email me directly! I am also happy to set up a quick chat if that's easier.

If you are starting to look into this for your organization, I pasted some quick references below to get you started.

Interested in other organizations process and policy on dispensing one dose in multiple syringes (i.e. large doses of subcut insulin, chemotherapy regimens):
1) If a single dose requires multiple syringes, do you require separate line items on the MAR?
2) Are you using one label for both syringes or labeling both with the same label and indicating 1/2, 2/2, etc?

Any insight would be appreciated!